Full Stack Engineering

QAI Labs Ltd. is a Delaware corporation headquartered in Sugar Land, Texas, with an Asia-Pacific origination footprint. Why QAI Labs QAI Labs is building NOVA-3, a computer-aided design platform for multi-specific antibodies — at the layer where molecular design decisions are made, not downstream of them. We are early-stage and intentional about it: the team is small, the problems are real, and the design choices you make now will be in the platform for years. If you want to work somewhere that takes scientific honesty and engineering craft seriously from the start, this is that company.

You should be comfortable with PyTorch, with reading recent antibody and protein design literature, and with the engineering reality of running benchmarks that other people will reproduce. Structural biology background or strong ML-for-biology track record required.

Build and manage partner conversations across Japan, Korea, and Southeast Asia

Qualify licensing, co-development, and platform access opportunities at early stage

Lead partner-facing technical presentations alongside the science team

Own deal pipeline tracking and surface high-priority conversations to founders

Requirements Prior BD or licensing experience in pharma or biotech

APAC network in pharma R&D or licensing an advantage

IND-readiness · CMC strategy · Phase 2 hire Will own regulatory strategy across our in-licensed programs as they move toward IND-readiness, including FDA and EMA interaction planning and CMC documentation strategy. Will run the wet-lab side of the data flywheel — partner-lab coordination, assay QC, sample logistics, and the data-back-into-platform pipeline that feeds NOVA-Evidence. J-18808-Ljbffr QAI Labs Ltd.